Changzhou Pharmaceutical Factory Ltd.,imwe kambani yeShanghai Pharmaceutical Holdings, yakagamuchira Drug Registration Certificate (Certificate No. 2021S01077, 2021S01078, 2021S01079) yakapihwa neState Drug AdministrationLenalidomide Capsules(Specification 5mg, 10mg, 25mg), iyo yakabvumirwa kugadzirwa.
Basic information
Zita remushongaLenalidomide capsules
Dosage fomu:Capsule
Tsanangudzo:5mg, 10mg, 25mg
Registration classification:Chemical drug class 4
Batch number:State Drug Certificate H20213802, State Drug Certificate H20213803, State Drug Certificate H20213804
Mhedziso yemvumo: Sangana nezvinodiwa zvekunyoreswa kwezvinodhaka, zvakatenderwa kunyoreswa, zvakapa chitupa chekunyoresa zvinodhaka.
Mashoko anoenderana
Lenalidomidechizvarwa chitsva cheoral immunomodulatory drug ine basa rekudzivisa bundu cell proliferation, inducing tumor cell apoptosis uye immunomodulation, inonyanya kushandiswa mukurapa myeloma yakawanda uye myelodysplastic syndrome (MDS) nemamwe mamiriro.Inoshandiswa pamwe chete nedexamethasone kurapa varwere vakura vane myeloma yakawanda isati yamborapwa avo vasiri vamiriri vekudyarwa.Ichi chigadzirwa chinoshandiswa pamwe chete nedexamethasone kurapa varwere vakura vane myeloma yakawanda vakawana kamwechete kamwechete kekutanga kurapwa.Ichi chigadzirwa chinoshandiswa pamwe chete ne rituximab kurapa varwere vakura vane follicular lymphoma (magiredhi 1-3a) vakambowana kurapwa.
Lenalidomide capsules akatanga kugadzirwa neCelgene Biopharmaceuticals uye akatengeswa kuUS muna 2005. muna Zvita 2019, Changzhou Pharmaceutical Factory yakaisa chikumbiro chekunyoresa uye chekushambadzira kuHurumende Drug Administration yemushonga, iyo yakagamuchirwa.
Dhata kubva kuMinene.com inoratidza kuti kutengeswa kwenyika kweNalidomide capsules muna 2020 kunenge kuri RMB 1.025 bhiriyoni.
Zvinoenderana nematongerwo enyika akakodzera, mhando dzemishonga yemageneric yakabvumidzwa zvinoenderana neiyo nyowani yekunyoreswa classification ichawana rutsigiro rwakakura munzvimbo dzakaita sekubhadhara inishuwarenzi yekurapa uye kutengwa kwechipatara.Naizvozvo, kugadzirwa kwakabvumidzwa kweChangzhou Pharmaceutical Factory's lenalidomidecapsule inobatsira kuti iwedzere kuwedzera chikamu chayo chemusika mumunda wehematology-tumor kurapwa uye kuwedzera kukwikwidza kwayo kwemusika, pamwe nekuunganidza ruzivo rwakakosha kune zvigadzirwa zvekambani zvinotevera kuita generic drug development uye kunyoresa kunyoresa.